Foradil, Foradil Certihaler, Perforomist, Duaklir Genuair (formoterol) is a small molecule pharmaceutical. Formoterol was first approved as Foradil on 2001-02-16. It is used to treat asthma and bronchial spasm in the USA. It has been approved in Europe to treat chronic obstructive pulmonary disease. The pharmaceutical is active against beta-2 adrenergic receptor. In addition, it is known to target beta-1 adrenergic receptor. Symbicort's patent is valid until 2021-06-22 (FDA).
|Trade Name||Duaklir Genuair|
|Indication||asthma, bronchial spasm, chronic obstructive pulmonary disease|
|Drug Class||Bronchodilators (phenethylamine derivatives)|